Harc: HIV accessory and regulatory complexes - the harc center: HIV accessory and regulatory complexes overall summary the harc center is an interdisciplinary program that aims to improve our…

Active Cooperative Agreement Awarded Last action

Award ID
U54AI170792
Recipient
Awarding agency
Obligated
$59,533,679

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 90% complete
Place of performance
San Francisco, CA 94143, USA

Award details come from USAspending.gov.

Description

Harc: HIV accessory and regulatory complexes - the harc center: HIV accessory and regulatory complexes overall summary the harc center is an interdisciplinary program that aims to improve our understanding of the interactions between HIV accessory and regulatory proteins and host cellular systems, with the ultimate goal to expand on therapeutic targets and treatment modalities for HIV/aids. The harc center will focus its efforts on the determination of structures of the accessory and regulatory proteins of HIV-1, with a focus on TAT, VIF and REV, in complex with their cellular partners, which have not been targets of HIV therapeutic modalities until now. A better molecular understanding of the functions and mechanisms of virus-host complexes may reveal new therapeutic strategies for intervention, including strategies of host-directed therapies, which may escape the limitations of current drug regimens where mutations in the targeted HIV enzymes can diminish drug efficacy. The harc center will determine the structures of these virus-host complexes using an integrated "systems-to- structure" platform that includes (1) discovery, through novel methods of functional proteomics and genetics being developed in the harc center, (2) validation through breakthrough crispr methods in primary T cells as well as targeted biochemical and functional assays, and (3) structure determination using a synthesis of innovative structural techniques developed in previous iterations of the harc center to address the large, flexible, heterogeneous and sometimes membrane-associated systems we study. The proposed research projects are centered around three themes that serve the center's goal. We will explore how HIV inhibits host restriction factors (theme 1), study the factors regulating HIV transcription and latency (theme 2) and investigate virus-host evolution (theme 3) across three projects: structure and evolution of VIF and APOBEC3 (project 1), regulation of HIV transcription and latency (project 2), and genetics and evolution (project 3). The harc center projects are supported by 4 technology cores covering proteomic approaches (core 1 - proteomics), crispr screens and endogenous tagging in primary cells to study virus- host function (core 2 - genetics), structural biology using cryo-electron microscopy, X-RAY screening and antibody technologies to determine the structures of HIV virus-host complexes (core 3 - structural biology), and integrative modeling of virus-host complexes (core 4 - computational). The overall goals, progress, and administration as well as outreach activities and communications will be overseen by the administrative core (core 5). The developmental core (core 6) will provide training opportunities to young investigators and harc center members and award the collaborative opportunity fund to enhance the center's overall research theme.

Transactions

Action Obligated Date
Amendment $5,719,529
Amendment Harc: HIV accessory and regulatory complexes - the mission of the administrative core is to support and promote the scientific and collaborative goals of the… $5,719,529
Amendment Equipment and administrative supplement- the harc center 2.0: HIV accessory and regulatory complexes - administrative supplements - the harc center 2.0: HIV… $500,000
Amendment $5,719,529
Amendment Equipment and administrative supplement- the harc center 2.0: HIV accessory and regulatory complexes - administrative supplements - the harc center 2.0: HIV… $5,719,529
Amendment $876,743
Amendment $876,743
Amendment $5,727,254
Amendment $5,727,254
Amendment $5,727,254
Amendment $5,740,105
Amendment $5,740,105
Original award $5,740,105
Show all 13

Subawards

Subrecipient Amount Awarded
Northwestern University Northwestern will provide modeling and cheminformatics support for medicinal chemistry, and develop Al-driven QSAR models to prioritize candidates for… $239,983
The University Of Iowa As PI of this proposal, I am listing 15% effort in salary, as the majority of salary costs are currently being funded through my K99/R00 award and startup… $155,500
Northwestern University Exploring the Antiviral Mechanism of HUWE1 E3 Ubiquitin Ligase during HIV-1 Infection HUWE1 (HECT, UBA and WWE domain containing E3 ubiquitin ligase 1) is an E3… $80,000
Uganda Virus Research Institute HIV-1 infection is a significant public health concern, with over 39 million people infected worldwide. The highest burden of HIV positive individuals resides… $98,235
The Leland Stanford Junior University Title: HLA protein modulation by HIV Nef in primary CD4+ T cells alters mechanisms of HIV recognition and control by natural killer cells. Successful control of… $231,600
University Of Texas At Dallas Human Immunodeficiency Virus (HIV) commandeers host cell pathways and cellular mechanisms during infection. While earlier work has shown that host cell… $234,000
J.david Gladstone Institutes Project Title: HARC 2.0 - CORE 2 Genetics Objectives The primary objective of the Marson lab will be to utilize their CRISPR knockout technology on human T… $849,478
J.david Gladstone Institutes Project Title: HARC 2.0 – Project 3 (Genetics and evolution): HIV-host interactions in primary human T cells Objectives The primary objective of the… $1,146,775
University Of North Carolina At Chapel Hill NC PI Name: Nancie M. Archin Project 2: U54AI170792 Sponsor Name: NIH Project Title: HARC: HIV accessory and regulatory complexes STATEMENT OF WORK Background… $876,943
Fred Hutchinson Cancer Center Fred Hutch PI Names: Michael Emerman and Harmit Malik Project 3: U54AI170792 Sponsor Name: NIH Project Title: HARC:HIV accessory and regulatory complexes… $2,209,072
Fred Hutchinson Cancer Center Fred Hutch PI Name: Lillian Cohn Project 2: U54AI170792 Sponsor Name: NIH Project Title: HARC: HIV accessory and regulatory complexes Start/end dates: Project… $992,552
Northwestern University Northwestern PI Name: Judd Hultquist Project 3: U54AI170792 Sponsor Name: NIH Project Title: HARC: HIV accessory and regulatory complexes STATEMENT OF WORK… $442,690
Northwestern University Northwestern PI Name: Judd Hultquist Core 2: U54AI170792 Sponsor Name: NIH Project Title: HARC: HIV accessory and regulatory complexes Start/end dates:… $273,756
Show all 13

Quick answers

Who received award U54AI170792?

U54AI170792 was awarded to The Regents Of The University Of California. San Francisco by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2022.

How much is award U54AI170792 worth?

$59,533,679 has been obligated on U54AI170792.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award